Literature DB >> 2478618

Functional identification of agretopic and epitopic residues within an HBcAg T cell determinant.

D R Milich1, J L Hughes, R Houghten, A McLachlan, J E Jones.   

Abstract

Residues 120-131 within the hepatitis B core Ag (HBcAg) represent a dominant T cell recognition site for mice of the H-2S haplotype. This study was undertaken in order to identify residues within the p120-131 sequence which either interact with the TCR termed epitopic residues or interact with MHC class II molecules termed agretopic residues. For this purpose a panel of analogs of p120-131 composed of peptides containing single alanine substitutions for each residue was synthesized. These peptides were analyzed functionally for their ability to stimulate p120-131 or HBcAg-primed T cells and for their immunogenicity in B10.S or [B10.S X B10 (nonresponder)]F1 mice. Furthermore, analogs of p120-131 were used as stimulators and inhibitors of T cell activation in competitive inhibition experiments. Cumulatively these functional studies allowed us to identify residue 125 as a dominant epitopic residue and residues 127 and 129 as dominant agretopic residues. Furthermore, a p120-131 analog containing an alanine substitution for the dominant agretopic residue was immunogenic in B10.S mice, but was nonimmunogenic in (B10.S X B10)F1 mice indicating that T cell responsiveness is influenced by MHC class II gene dosage effects and can be inherited in an apparent recessive manner. In this study, critical residues involved in the immunogenicity of this dominant T cell determinant of HBcAg were defined, in a companion study, the influence of these residues on tolerogenicity was examined.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478618

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Variations in codons 84-101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection.

Authors:  T Ehata; M Omata; O Yokosuka; K Hosoda; M Ohto
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

Review 2.  Mechanisms of genetic control of murine systemic lupus erythematosus.

Authors:  S Izui; R Merino; M Iwamoto; L Fossati
Journal:  Springer Semin Immunopathol       Date:  1994

3.  Analysis of the uveitogenic determinant in repeat structure of retinal interphotoreceptor retinoid-binding protein (IRBP).

Authors:  H Inoue; M Takeuchi; T Tanaka; M Usui; S Ando; O Taguchi
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

4.  Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis.

Authors:  T Ehata; M Omata; W L Chuang; O Yokosuka; Y Ito; K Hosoda; M Ohto
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

5.  The Yaa gene abrogates the major histocompatibility complex association of murine lupus in (NZB x BXSB)F1 hybrid mice.

Authors:  R Merino; M Iwamoto; M E Gershwin; S Izui
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

6.  Autoantibody production in hepatitis B e antigen transgenic mice elicited with a self T-cell peptide and inhibited with nonself peptides.

Authors:  D R Milich; A McLachlan; A K Raney; R Houghten; G B Thornton; T Maruyama; J L Hughes; J E Jones
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

7.  Preferential recognition of hepatitis B nucleocapsid antigens by Th1 or Th2 cells is epitope and major histocompatibility complex dependent.

Authors:  D R Milich; D L Peterson; F Schödel; J E Jones; J L Hughes
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

8.  Antibody-dependent cell-mediated cytotoxicity against cell lines generated by liver-specific idiotype-bearing antibody.

Authors:  T Kagawa; H Saito; T Morizane; K Tsuchimoto; Y Inagaki; K Sawaguchi; N Iwabuchi; N Kumagai; M Tsuchiya; H Ishii
Journal:  J Gastroenterol       Date:  1995-04       Impact factor: 7.527

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.